ro]

 

i : INBIFO Institut far biologische Forschung GmbH - KéIn PRIORITY
i i Report P 0500/3237 97/10/8 Page 71
| I
7 ~ 1200
& 4 + VIRGO-CA
2 © : VIRGO-CC
3 Oo : 1R4F
FP eee : without $9
& 1000 ——  : with $9
9
Zz
o
<
3
=

 

 

 

 

600 +
400 |
r ; 200

TPM DOSE (mg/plate)

Figure 5 Mutagenicity of TPM in Strain TA1537

 

Remarks: mean + SE, N = 12 plates
data see Tables 5, 11, 15, 26, 27, 34, and 35

 

SELLLL790c